Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2005 5
2006 4
2007 1
2008 6
2009 3
2010 2
2011 5
2012 4
2014 7
2015 7
2016 4
2017 6
2018 1
2019 4
2020 4
2021 2
2022 2
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer.
Okuno K, Kandimalla R, Mendiola M, Balaguer F, Bujanda L, Fernandez-Martos C, Aparicio J, Feliu J, Tokunaga M, Kinugasa Y, Maurel J, Goel A. Okuno K, et al. Among authors: aparicio j. Mol Cancer. 2023 Jan 20;22(1):13. doi: 10.1186/s12943-022-01699-2. Mol Cancer. 2023. PMID: 36670412 Free PMC article. No abstract available.
Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning.
Muñoz AJ, Souto JC, Lecumberri R, Obispo B, Sanchez A, Aparicio J, Aguayo C, Gutierrez D, Palomo AG, Fanjul V, Del Rio-Bermudez C, Viñuela-Benéitez MC, Hernández-Presa MÁ. Muñoz AJ, et al. Among authors: aparicio j. Thromb Res. 2023 Aug;228:181-188. doi: 10.1016/j.thromres.2023.06.015. Epub 2023 Jun 16. Thromb Res. 2023. PMID: 37348318
Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.
Boormans JL, Sylvester R, Anson-Cartwright L, Glicksman RM, Hamilton RJ, Hahn E, Daugaard G, Lauritsen J, Wagner T, Avuzzi B, Nicolai N, Del Muro XG, Aparicio J, Stalder O, Rothermundt C, Fischer S, Laguna MP. Boormans JL, et al. Among authors: aparicio j. Eur Urol Oncol. 2023 Nov 9:S2588-9311(23)00232-8. doi: 10.1016/j.euo.2023.10.014. Online ahead of print. Eur Urol Oncol. 2023. PMID: 37951820
Management options for stage I seminoma.
Aparicio J, Díaz R. Aparicio J, et al. Expert Rev Anticancer Ther. 2010 Jul;10(7):1077-85. doi: 10.1586/era.10.82. Expert Rev Anticancer Ther. 2010. PMID: 20645697 Review.
Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer.
González-Billalabeitia E, Sepúlveda JM, Maroto P, Aparicio J, Arranz JA, Esteban E, Gironés R, López-Brea M, Mendez-Vidal MJ, Pinto A, Sastre J, de Prado DS, Terrasa J, Vázquez S, Powles T, Beyer J, Castellano D, Del Muro XG; Spanish Germ Cell Cancer Group and the Spanish Oncology Genitourinary Group. González-Billalabeitia E, et al. Among authors: aparicio j. Eur Urol Focus. 2017 Apr;3(2-3):280-286. doi: 10.1016/j.euf.2016.07.002. Epub 2016 Jul 18. Eur Urol Focus. 2017. PMID: 28753776 Review.
71 results